|
|
||||||||
ANTIMICROBIAL RESISTANCE |
Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
Corresponding author: Dr E. E. Udo (e-mail: EDET{at}hsc.kuniv.edu.kw).
Received 14 Feb. 2001; revised version accepted 6 April 2001.
Abstract
Clinical strains of methicillin-resistant Staphylococcus aureus (MRSA) expressing high- and low-level mupirocin resistance were studied to determine the genetic location of mupirocin and other resistance determinants. Mupirocin resistance was confirmed by MIC determination with E-test strips. Curing and transfer experiments were used to establish the genetic location of the resistance determinants and the PCR with mupAp-specific primers was used to detect the presence of mupA genes. High-level mupirocin- resistant isolates had MICs >10245mumg/L, whereas the low-level resistant isolates had MICs of 321285mumg/L. The isolates carried plasmids ranging from 2.8 to 38 kb in size. All of them carried 26- and 3.0-kb plasmids, but only the high-level mupirocin-resistant isolates carried a 38-kb plasmid. Curing and transfer experiments revealed that the 26-kb plasmid encoded resistance to cadmium, mercuric chloride, propamidine isethionate and ethidium bromide and the 38-kb plasmid was a conjugative plasmid encoding high-level mupirocin resistance. One isolate, IBN287, carried both plasmid-borne high-level and chromosomal low-level mupirocin resistance. The mupA gene was detected on the 38-kb plasmid DNA but not in the genomic DNA of the low-level mupirocin-resistant isolates. The genomic DNA of strain IBN287 cured of the 38-kb mupirocin resistance plasmid did not contain mupA. The results suggest that different genes encoded low-and high-level mupirocin resistance in these isolates.
This article has been cited by other articles:
![]() |
A. E. Simor, T. L. Stuart, L. Louie, C. Watt, M. Ofner-Agostini, D. Gravel, M. Mulvey, M. Loeb, A. McGeer, E. Bryce, et al. Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3880 - 3886. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Paule, A. C. Pasquariello, D. M. Hacek, A. G. Fisher, R. B. Thomson Jr, K. L. Kaul, and L. R. Peterson Direct Detection of Staphylococcus aureus from Adult and Neonate Nasal Swab Specimens Using Real-Time Polymerase Chain Reaction J. Mol. Diagn., August 1, 2004; 6(3): 191 - 196. [Abstract] [Full Text] |
||||
![]() |
E. E. Udo, N. Al-Sweih, and B. C. Noronha A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance J. Antimicrob. Chemother., May 1, 2003; 51(5): 1283 - 1286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |